<DOC>
	<DOCNO>NCT02077348</DOCNO>
	<brief_summary>Diabetes mellitus type I ( DM I ) characterize lack endogenous insulin patient 100 % dependent insulin substitution survive . Insulin potent anabolic hormone primary target liver , skeletal muscle-tissue - adipose-tissue . Severe lack insulin lead elevate blood glucose level , dehydration , electrolyte derangement , ketosis thus eventually ketoacidosis . Insulin signal pathway well-known . Growth hormone ( GH ) also potent anabolic hormone , responsible human growth preservation protein fast . GH ( concert lack insulin ) induce lipolysis fasting . It known GH exert lipolytic action . The aim define insulin growth hormone ( GH ) signal pathway 3 different state patient DM I . And test whether ATGL-related lipolysis adipose tissue contributes development ketosis . 1 . Good glycemic control 2 . Lack insulin ( ketosis/ketoacidosis ) 3 . Good glycemic control GH injection</brief_summary>
	<brief_title>Metabolic Signalling Muscle- Adipose-tissue Following Insulin Withdrawal Growth Hormone Injection .</brief_title>
	<detailed_description>Diabetes mellitus type I ( DMI ) characterize lack endogenous insulin patient 100 % dependent insulin substitution survive . Insulin potent anabolic hormone primary target in- liver , -the skeletal muscle-tissue - fat-tissue . In liver enhances glycogenesis inhibits glycogenolysis gluconeogenesis . In skeletal muscle-tissue , enhances glucose transport cell , glycogenesis , glycolysis , glucose oxidation protein synthesis . In fat-tissue , inhibit lipolysis enhances lipogenesis . This indicate fall serum insulin level lead increase blood glucose increase level FFA 's ( free fatty acid ) blood - eventually lead ketone production . If condition correct , lead ketoacidosis , potentially life-threatening condition , correct hospital admission fluid-therapy , electrolyte- insulin-substitution . Insulin study thoroughly signal pathway well know . An interesting pathway suppression lipolysis . The important rate-limiting lipase triglyceride hydrolysis adipose triglyceride lipase ( ATGL ) ( 1-5 ) . A connection ATGL G0/G1 switch gene ( G0S2 ) show ( 6,7 ) . During lipolysis ATGL up-regulated G0S2 down-regulated promoter region G0S2 binding-sites glucose , insulin dependent transcription factor peroxisome proliferator-activated receptor ( PPAR-y ) ( 8 ) . One former study show fasting reduces G0S2 increase ATGL humane adipose-tissue ( 7 ) . The anti-lipolytic effect insulin , could think , mediate increased transcription G0S2 turn inhibits ATGL . Conversely , increase lipolysis lack insulin . Growth hormone growth hormone dependent synthesis og IGF-1 ( Insulin-like growth factor - 1 ) crucial human growth adolescence . As adult GH IGF-1 still potent growth factor also exert essential regulatory property human metabolism ( 9,10 ) GH- signalling pathway go GH-receptor , phosphorylates thus activates receptor associate Janus Kinase 2 ( JAK2 ) . The signal point examine numerous study . In rodent , signal show run three way ( 9,10 ) Studies human fibroblast cell able support two pathway ( MAPK - mitogen-activated protein kinase STAT - signal transducer activator transcription ) , insulin receptor substrate ( IRS ) phosphatidylinositol 3-kinase ( PI3-K ) pathway . In human ( vivo ) study , GH stimulation phosphorylation STAT5 evident , however association GH stimulation activation MAPK PI3-K show ( 11 ) . The latter interesting remarkable , consider insulin-agonistic antagonistic effect GH . GH stimulate lipolysis , exactly lipolytic property GH mediate fully understood . However , show GH effect hormone-sensitive lipase ( 12 ) ( HSL ) . Other option could , find rodent , interaction via PI3-K signal pathway via G0S2/ATGL interaction , either directly perhaps mediate IGF-1 . Humane intracellular signaling-pathways development ketosis/ketoacidosis well-known . The investigator believe understand pathway exact mechanism behind development ketoacidosis , great importance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Diagnosis Diabetes Mellitus Type I , Cpeptide negative , 19 &lt; BMI &lt; 26 , Written consent Ischemic heart disease , Cardiac arrythmia , Epilepsy , Other medical illness</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Diabetes Mellitus type I</keyword>
	<keyword>Ketoacidosis</keyword>
	<keyword>Insulin withdrawal</keyword>
	<keyword>Growth hormone injection</keyword>
	<keyword>Lipolysis ATGL</keyword>
</DOC>